Prediction of Abdominal Aortic Aneurysm Growth by Automatic Segmentation and Radiomics Feature Quantification

An accurate assessment of abdominal aortic aneurysm (AAA) progression is essential to its clinical management. Currently, the maximum diameter of AAA at diagnosis is considered as the primary indicator of rupture risk. However, it is not optimal as rupture can happen at any size. Several patient-specific factors may also influence AAA rupture risk. Given the clinical variability in aneurysm progression, additional prognostic markers are desirable to enhance patient-specific risk stratification. Radiomics is an image processing technique that extracts quantitative and high-dimensional features from medical images. While it has emerged as a novel approach for solving diagnosis in oncology, its application in cardiovascular diseases is still limited. This study set out with an aim to determine the feasibility of radiomics in identifying AAA with a fast growth rate (>0.3cm/year) using CT images. An automatic AAA segmentation algorithm was developed in our pipeline. Based on the radiomics features of an 84 CT dataset, supervised classification models were implemented with two feature selection algorithms and two classifiers in a machine-learning framework. An AUC of 0.80 was achieved and the predictive power was proved through comparisons to the maximum diameter and conventional risk factors. Further multivariate analysis suggested that a radiomics-based classification model could be used as an independent, yet strong predictor for fast AAA growth rate

AI deployment on GBM diagnosis: a novel approach to analyze histopathological images using image feature-based analysis

Background: Glioblastoma (GBM) is one of the most common malignant primary brain tumors, which accounts for 60–70% of all gliomas. Conventional diagnosis and the decision of post-operation treatment plan for glioblastoma is mainly based on the feature-based qualitative analysis of hematoxylin and eosin-stained (H&amp;E) histopathological slides by both an experienced medical technologist and a pathologist. The recent development of digital whole slide scanners makes AI-based histopathological image analysis feasible and helps to diagnose cancer by accurately counting cell types and/or quantitative analysis. However, the technology available for digital slide image analysis is still very limited. This study aimed to build an image feature-based computer model using histopathology whole slide images to differentiate patients with glioblastoma (GBM) from healthy control (HC). Method: Two independent cohorts of patients were used. The first cohort was composed of 262 GBM patients of the Cancer Genome Atlas Glioblastoma Multiform Collection (TCGA-GBM) dataset from the cancer imaging archive (TCIA) database. The second cohort was composed of 60 GBM patients collected from a local hospital. Also, a group of 60 participants with no known brain disease were collected. All the H&amp;E slides were collected. Thirty-three image features (22 GLCM and 11 GLRLM) were retrieved from the tumor volume delineated by medical technologist on H&amp;E slides. Five machine-learning algorithms including decision-tree (DT), extreme-boost (EB), support vector machine (SVM), random forest (RF), and linear model (LM) were used to build five models using the image features extracted from the first cohort of patients. Models built were deployed using the selected key image features for GBM diagnosis from the second cohort (local patients) as model testing, to identify and verify key image features for GBM diagnosis. Results: All five machine learning algorithms demonstrated excellent performance in GBM diagnosis and achieved an overall accuracy of 100% in the training and validation stage. A total of 12 GLCM and 3 GLRLM image features were identified and they showed a significant difference between the normal and the GBM image. However, only the SVM model maintained its excellent performance in the deployment of the models using the independent local cohort, with an accuracy of 93.5%, sensitivity of 86.95%, and specificity of 99.73%. Conclusion: In this study, we have identified 12 GLCM and 3 GLRLM image features which can aid the GBM diagnosis. Among the five models built, the SVM model proposed in this study demonstrated excellent accuracy with very good sensitivity and specificity. It could potentially be used for GBM diagnosis and future clinical application.</p

Breast cancer classification through multivariate radiomic time series analysis in DCE-MRI sequences

Breast cancer is the most prevalent disease that poses a significant threat to women’s health. Despite the Dynamic Contrast-Enhanced MRI (DCE-MRI) has been widely used for breast cancer classification, its diagnostic performance is still suboptimal. In this work, the Radiomic workflow was implemented to classify the whole DCE-MRI sequence based on the distinction in contrast agent uptake between benign and malignant lesions. The radiomic features extracted from each of the seven time instants within the DCE-MRI sequence were fed into a multi-instant features selection strategy to select the discriminative features for time series classification. Several time series classification algorithms including Rocket, MultiRocket, K-Nearest Neighbor, Time Series Forest, and Supervised Time Series Forest were compared. Firstly, a univariate classification was performed to find the five most informative radiomic series, and then, a multivariate time series classification was implemented via a voting mechanism. The Multivariate Rocket model was the most accurate (Accuracy = 0.852, AUC-ROC = 0.852, Specificity = 0.823, Sensitivity = 0.882). The intelligible radiomic features enabled model findings explanations and clinical validation. In particular, the Energy and TotalEnergy were among the most important features, and the most descriptive for the change in signal intensity, which is the main effect of the contrast agent

AI-enhanced diagnosis of challenging lesions in breast MRI: a methodology and application primer

Computer-aided diagnosis (CAD) systems have become an important tool in the assessment of breast tumors with magnetic resonance imaging (MRI). CAD systems can be used for the detection and diagnosis of breast tumors as a “second opinion” review complementing the radiologist’s review. CAD systems have many common parts such as image pre-processing, tumor feature extraction and data classification that are mostly based on machine learning (ML) techniques. In this review paper, we describe the application of ML-based CAD systems in MRI of the breast covering the detection of diagnostically challenging lesions such as non-mass enhancing (NME) lesions, multiparametric MRI, neo-adjuvant chemotherapy (NAC) and radiomics all applied to NME. Since ML has been widely used in the medical imaging community, we provide an overview about the state-ofthe-art and novel techniques applied as classifiers to CAD systems. The differences in the CAD systems in MRI of the breast for several standard and novel applications for NME are explained in detail to provide important examples illustrating: (i) CAD for the detection and diagnosis, (ii) CAD in multi-parametric imaging (iii) CAD in NAC and (iv) breast cancer radiomics. We aim to provide a comparison between these CAD applications and to illustrate a global view on intelligent CAD systems based on ANN in MRI of the breast

Deep PCCT: Photon Counting Computed Tomography Deep Learning Applications Review

Medical imaging faces challenges such as limited spatial resolution, interference from electronic noise and poor contrast-to-noise ratios. Photon Counting Computed Tomography (PCCT) has emerged as a solution, addressing these issues with its innovative technology. This review delves into the recent developments and applications of PCCT in pre-clinical research, emphasizing its potential to overcome traditional imaging limitations. For example PCCT has demonstrated remarkable efficacy in improving the detection of subtle abnormalities in breast, providing a level of detail previously unattainable. Examining the current literature on PCCT, it presents a comprehensive analysis of the technology, highlighting the main features of scanners and their varied applications. In addition, it explores the integration of deep learning into PCCT, along with the study of radiomic features, presenting successful applications in data processing. While acknowledging these advances, it also discusses the existing challenges in this field, paving the way for future research and improvements in medical imaging technologies. Despite the limited number of articles on this subject, due to the recent integration of PCCT at a clinical level, its potential benefits extend to various diagnostic applications